Chicago Bears GM Ryan Poles provided an update on cornerback Jaylon Johnson, who suffered an injury while training.

The turmoil in Congress over the Jeffrey Epstein probe isn't going away anytime soon after the House Speaker ended the legislative session early before the August break.

Players are working to earn Johnson's trust, but he's working to do the same as he tries to end the Bears' run of fizzling coaches.

Johnson & Johnson MedTech expanded its campus in Santa Clara as it continues to invest in robotically-assisted surgery devices.

We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ)’s shares are up by 5% since its latest earnings report,

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast on Wednesday after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.

Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish technical momentum. Learn more on JNJ stock here.

The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a record low at around 1.2%). That high-yielding payout is very healthy, making Johnson & Johnson a very safe way to collect dividend income.

Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for enforcement against smoking says the mayor’s ideas could lack teeth.